These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 917168)

  • 1. Removal of guanidinosuccinic acid by hemodialysis.
    Perez G; Abraira C; Rey A; Horn M
    Nephron; 1977; 19(4):214-9. PubMed ID: 917168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential removal of guanidinosuccinic acid and creatine by hemodialysis and continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Billiouw JM; Becaus I; Lornoy W
    Nephron; 1991; 57(3):369-70. PubMed ID: 2017282
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD; Gordon SI; Wang M; Swendseid ME
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte transketolase activity and guanidino compounds in hemodialysis patients.
    Pietrzak I; Baczyk K
    Kidney Int Suppl; 2001 Feb; 78():S97-101. PubMed ID: 11168992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiautomated method for measurement of guanidinosuccinic acid in serum.
    Kamoun PP; Pleau JM; Man NK
    Clin Chem; 1972 Apr; 18(4):355-7. PubMed ID: 5012258
    [No Abstract]   [Full Text] [Related]  

  • 7. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 9. Guanidinosuccinic acid on human platelet. Effects of exogenous urea, creatinine, and aggregation in vitro.
    Davis JW; McField JR; Phillips PE; Graham BA
    Blood; 1972 Mar; 39(3):388-97. PubMed ID: 5059649
    [No Abstract]   [Full Text] [Related]  

  • 10. New method for measurement of guanidinosuccinic acid in serum and urine.
    Gróf J; Tankó A; Menyhárt J
    Clin Chem; 1974 May; 20(5):574-5. PubMed ID: 4826951
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of guanidinosuccinic acid in rat blood and cerebrospinal fluid.
    Kasai Y; Akanuma S; Kubo Y; Tachikawa M; Hosoya K
    Drug Metab Pharmacokinet; 2014; 29(1):97-100. PubMed ID: 23955547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid.
    Marescau B; De Deyn PP; Qureshi IA; De Broe ME; Antonozzi I; Cederbaum SD; Cerone R; Chamoles N; Gatti R; Kang SS
    Metabolism; 1992 Sep; 41(9):1021-4. PubMed ID: 1518417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A striking rise of serum guanidinosuccinic acid (s-GSA) in the critical period of CRF].
    Haruki K; Hirata M; Muramoto H; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):821-5. PubMed ID: 3249449
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of methionine on the level of guanidinosuccinic acid in patients with uremia].
    Ksiazek A
    Pol Arch Med Wewn; 1977 Aug; 58(2):127-32. PubMed ID: 905158
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.
    Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R
    Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.
    Horowitz HI; Stein IM; Cohen BD; White JG
    Am J Med; 1970 Sep; 49(3):336-45. PubMed ID: 5455565
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.